生物活性 | |||
---|---|---|---|
描述 | N-Methylcytisine(NMC), a tricyclic quinolizidine alkaloid, exerts hypoglycaemic, analgesic and anti-inflammatory activities. Oral administration (1, 4 and 16 mg/kg) of NMC attenuated the DSS(dextran sulfate sodium)-induced clinical symptoms and pathological damage. In addition, NMC treatment significantly reduced myeloperoxidase activity and level of pro-inflammatory cytokines. NMC blocked the activation of NF-κB by inhibiting IκB and IKK phosphorylation[3]. N-methylcytisine is a selective ligand of nicotinic receptors of acetylcholine in the central nervous system and has a high affinity (Kd = 50 nM) to nicotinic acetylcholine receptors (nAChR) from squid optical ganglia[4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.90mL 0.98mL 0.49mL |
24.48mL 4.90mL 2.45mL |
48.96mL 9.79mL 4.90mL |
参考文献 |
---|